435 related articles for article (PubMed ID: 27085554)
41. Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical and molecular features.
Kunju LP; Wojno K; Wolf JS; Cheng L; Shah RB
Hum Pathol; 2008 Jan; 39(1):96-101. PubMed ID: 17949780
[TBL] [Abstract][Full Text] [Related]
42. PAX8 is expressed in the majority of renal epithelial neoplasms: an immunohistochemical study of 223 cases using a mouse monoclonal antibody.
Hu Y; Hartmann A; Stoehr C; Zhang S; Wang M; Tacha D; Montironi R; Lopez-Beltran A; Cheng L
J Clin Pathol; 2012 Mar; 65(3):254-6. PubMed ID: 22135028
[TBL] [Abstract][Full Text] [Related]
43. Low grade oncocytic renal tumor (LOT): Clinicopathological characterization of 13 cases.
Almutairi F; Xu B
Pathol Res Pract; 2024 Feb; 254():155127. PubMed ID: 38241777
[TBL] [Abstract][Full Text] [Related]
44. The Role of CK7, S100A1, and CD82 (KAI1) Expression in the Differential Diagnosis of Chromophobe Renal Cell Carcinoma and Renal Oncocytoma.
Sari ZB; Açikalin MF; Arik D; Özen A; Can C; Çolak E
Appl Immunohistochem Mol Morphol; 2021 Aug; 29(7):534-540. PubMed ID: 33605572
[TBL] [Abstract][Full Text] [Related]
45. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases.
Pan CC; Chen PC; Ho DM
Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648
[TBL] [Abstract][Full Text] [Related]
46. Renal cell carcinomas with tubulopapillary architecture and oncocytic cells: Molecular analysis of 39 difficult tumors to classify.
Pivovarcikova K; Grossmann P; Hajkova V; Alaghehbandan R; Pitra T; Perez Montiel D; Sperga M; Rogala J; Slisarenko M; Bartos Vesela A; Svajdler P; Michalova K; Rotterova P; Hora M; Michal M; Hes O
Ann Diagn Pathol; 2021 Jun; 52():151734. PubMed ID: 33838490
[TBL] [Abstract][Full Text] [Related]
47. Active surveillance is suitable for intermediate term follow-up of renal oncocytoma diagnosed by percutaneous core biopsy.
Liu S; Lee S; Rashid P; Bangash H; Hamid A; Lau J; Cohen R
BJU Int; 2016 Oct; 118 Suppl 3():30-34. PubMed ID: 27457972
[TBL] [Abstract][Full Text] [Related]
48. Caveolin-1 immunohistochemical analysis in differentiating chromophobe renal cell carcinoma from renal oncocytoma.
Garcia E; Li M
Am J Clin Pathol; 2006 Mar; 125(3):392-8. PubMed ID: 16613342
[TBL] [Abstract][Full Text] [Related]
49. Hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinomas and oncocytomas have excellent oncologic outcomes.
Waldert M; Klatte T; Haitel A; Ozsoy M; Schmidbauer J; Marberger M; Remzi M
Eur Urol; 2010 Apr; 57(4):661-5. PubMed ID: 19477583
[TBL] [Abstract][Full Text] [Related]
50. Oncocytic papillary renal cell carcinoma: a clinicopathological study emphasizing distinct morphology, extended immunohistochemical profile and cytogenetic features.
Xia QY; Rao Q; Shen Q; Shi SS; Li L; Liu B; Zhang J; Wang YF; Shi QL; Wang JD; Ma HH; Lu ZF; Yu B; Zhang RS; Zhou XJ
Int J Clin Exp Pathol; 2013; 6(7):1392-9. PubMed ID: 23826421
[TBL] [Abstract][Full Text] [Related]
51. Concordance of MTOR Pathway Mutations and the Diagnosis of Renal Low-Grade Oncocytic Tumor (LOT).
Siegmund SE; Al-Obaidy KI; Tsai HK; Idrees MT; Akgul M; Acosta AM; Hirsch MS
Int J Surg Pathol; 2024 Apr; 32(2):316-330. PubMed ID: 37357748
[TBL] [Abstract][Full Text] [Related]
52. Renal oncocytoma with and without intravascular extension into the branches of renal vein have the same morphological, immunohistochemical, and genetic features.
Hes O; Michal M; Síma R; Vanecek T; Brunelli M; Martignoni G; Kuroda N; Alvarado Cabrero I; Perez-Montiel D; Hora M; Urge T; Dvorák M; Jarosová M; Yang X
Virchows Arch; 2008 Feb; 452(2):193-200. PubMed ID: 18066590
[TBL] [Abstract][Full Text] [Related]
53. A case of oncocytic papillary renal cell carcinoma.
Okada A; Sasaki S; Fujiyoshi Y; Niimi K; Kurokawa S; Umemoto Y; Kohri K
Int J Urol; 2009 Sep; 16(9):765-7. PubMed ID: 19769658
[TBL] [Abstract][Full Text] [Related]
54. Biphasic Squamoid Alveolar Renal Cell Carcinoma: A Distinctive Subtype of Papillary Renal Cell Carcinoma?
Hes O; Condom Mundo E; Peckova K; Lopez JI; Martinek P; Vanecek T; Falconieri G; Agaimy A; Davidson W; Petersson F; Bulimbasic S; Damjanov I; Jimeno M; Ulamec M; Podhola M; Sperga M; Pane Foix M; Shelekhova K; Kalusova K; Hora M; Rotterova P; Daum O; Pivovarcikova K; Michal M
Am J Surg Pathol; 2016 May; 40(5):664-75. PubMed ID: 26999503
[TBL] [Abstract][Full Text] [Related]
55. Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.
Aron M; Chang E; Herrera L; Hes O; Hirsch MS; Comperat E; Camparo P; Rao P; Picken M; Michal M; Montironi R; Tamboli P; Monzon F; Amin MB
Am J Surg Pathol; 2015 Jul; 39(7):873-88. PubMed ID: 25970682
[TBL] [Abstract][Full Text] [Related]
56. Role of immunohistochemistry in the evaluation of needle core biopsies in adult renal cortical tumors: an ex vivo study.
Al-Ahmadie HA; Alden D; Fine SW; Gopalan A; Touijer KA; Russo P; Reuter VE; Tickoo SK
Am J Surg Pathol; 2011 Jul; 35(7):949-61. PubMed ID: 21677535
[TBL] [Abstract][Full Text] [Related]
57. Surgical histopathology for suspected oncocytoma on renal mass biopsy: a systematic review and meta-analysis.
Patel HD; Druskin SC; Rowe SP; Pierorazio PM; Gorin MA; Allaf ME
BJU Int; 2017 May; 119(5):661-666. PubMed ID: 28058773
[TBL] [Abstract][Full Text] [Related]
58. Can renal oncocytomas be distinguished from renal cell carcinoma on fine-needle aspiration specimens? A study of conventional smears in conjunction with ancillary studies.
Liu J; Fanning CV
Cancer; 2001 Dec; 93(6):390-7. PubMed ID: 11748579
[TBL] [Abstract][Full Text] [Related]
59. Renal oncocytoma with and without intravascular extension into the branches of renal vein have the same morphological, immunohistochemical and genetic features.
Hes O; Michal M; Síma R; Vanecek T; Brunelli M; Martignoni G; Kuroda N; Cabrero IA; Perez-Montiel D; Hora M; Urge T; Dvorák M; Jarosová M; Yang X
Virchows Arch; 2008 Mar; 452(3):285-93. PubMed ID: 18196270
[TBL] [Abstract][Full Text] [Related]
60. Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.
Green WM; Yonescu R; Morsberger L; Morris K; Netto GJ; Epstein JI; Illei PB; Allaf M; Ladanyi M; Griffin CA; Argani P
Am J Surg Pathol; 2013 Aug; 37(8):1150-63. PubMed ID: 23715164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]